Companies: 10,795·Total market cap: $144.5T
Medigene AG

Medigene AG

MDGEFOTCHealthcare● Active
$2.59
+$0.00(+0.00%)
Market Cap$38170366
P/E Ratio—
52W High$2.59
52W Low$0.1
Overview

Medigene AG (MDGEF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MDGEF · cash on hand · updated Dec 31, 2023

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$16.7M▼ -49.8% vs prior year
FY · as of Dec 31, 2023 · Reported in EUR
Cash & Cash Equiv. (CCE)
$8.7M
cashAndCashEquivalents
Short-Term Investments
$8.0M
shortTermInvestments
YoY Change vs Prior Year
-49.8%
vs prior fiscal year
Latest Quarter
$14.0M
Q2 2024
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in EUR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2023

Net cash vs debt

Cash & ST Investments$16.7MCash on Hand
Total Debt$3.0MTotal Debt
Net Cash / Net Debt+$13.7MNet Cash Position
Cash vs Debt Ratio
Cash 85%Debt 15%

Medigene AG has a net cash position of $13.7M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$16.7M − $3.0M = +$13.7M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MDGEF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2023Latest$16.7M-49.8%
Dec 31, 2022$33.2M+48.2%
Dec 31, 2021$22.4M-25.4%
Dec 31, 2020$30.0M-45.1%
Dec 31, 2019$54.7M+6.4%
MDGEF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.5%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Medigene AG
Medigene AGYOU
MDGEF
$16.7M43.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Medigene AG (MDGEF) cash on hand as of December 31, 2023 is $16.7M, comprising $8.7M in cash and cash equivalents (CCE) plus $8.0M in short-term investments — reported as Medigene AG cash and short-term investments on the balance sheet (10-K filing). Also referred to as Medigene AG cash reserves or cash position.

Medigene AG annual cash on hand history shows decreased -49.8% in 2023: decreased -49.8% in 2023. Medigene AG cash reserves in 2023 reflect the company's capital allocation strategy.

Medigene AG carries total debt of $3.0M against cash of $16.7M, resulting in a net cash position of +$13.7M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MDGEF cash on hand · 5 questions

As of December 31, 2023, Medigene AG (MDGEF) has $16,674,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $8,674,000 in cash and cash equivalents (CCE) plus $8,000,000 in short-term investments. Latest quarter (June 30, 2024): $14,024,000. Data sourced from the annual 10-K filing via FMP.

MDGEF cash on handMDGEF cash reservesMDGEF cash 2023how much cash does MDGEF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Medigene AG · Medigene AG SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2023